AcuraStem
AcuraStem is a patient-based biotechnology company developing treatments for neurodegenerative diseases like ALS and FTD. They utilize their iNeuroRx platform to model diseases in patient neurons, enabling the rapid discovery and testing of treatments, such as antisense oligonucleotides (ASOs). Their research focuses on targets like UNC13A and SYF2 to address TDP-43 pathology.
Funding Round: Grant
Funding Amount: $7M
Date: 30-Jan-2024
Investors: National Institutes of Health (NIH), Department of Defense (DOD)
Markets: Biotechnology, Healthtech, Neurodegenerative Diseases
HQ: Pasadena, California, United States
Founded: 2016
Website: https://acurastem.com/
LinkedIn: https://www.linkedin.com/company/12903559/
Twitter: https://twitter.com/acurastem
Facebook: https://fb.me/AcuraStem
Crunchbase: https://www.crunchbase.com/organization/acurastem
Leave a Comment
Comments
No comments yet.